[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![NightOwlBiotech Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1680659305698033664.png) Night Owl Biotech Research Group [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) on x 1155 followers
Created: 2025-05-06 02:39:00 UTC

Cumulative $ARDX analyst consensus revenue estimates by year thru patent exp in FY34. Absent a meaningful pipeline the odds are overwhelming S/Hs are best served by M&A. See $PHAT last Nov (not last week) when it was thought patents may expire X years early. Comments? $XBI $LABU

![](https://pbs.twimg.com/media/GqO6JT3WwAAXAPj.png)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1919582642980241825/c:line.svg)

**Related Topics**
[labu](/topic/labu)
[$labu](/topic/$labu)
[$xbi](/topic/$xbi)
[$phat](/topic/$phat)
[$ardx](/topic/$ardx)

[Post Link](https://x.com/NightOwlBiotech/status/1919582642980241825)